About us
About Pharmetheus
History
Mission & Values
Leadership
Scientific advisors
Our team
Social impact (CSR)
Science & Services
Contexts of use
Trial design and analysis
Program strategies and efficiences
Special/specific populations
Special considerations
Regulatory interactions
Pharmetheus Platforms
Model-Informed Drug Development
PBPK & PBBM
Pharmacometrics
QSP
Solutions
Milestone Analysis
Embedded Scientists
Expert Advice
Scientific Publication
Specific services
Model-Informed Bioequivalence & Biosimilarity
Accelerated submission
Concentration-QTc (C-QTc) modeling
Data-driven strategies for pediatric success
Training workshops
Publications
Case studies
Articles
Careers
Working with us
Open positions
Employee stories
Events
News
Contact us
Home
Publications
Overview of Authorized Drug Products for Subcutaneous Administration: Pharmaceutical, Therapeutic, and Physicochemical Properties
Overview of Authorized Drug Products for Subcutaneous Administration: Pharmaceutical, Therapeutic, and Physicochemical Properties
Program strategies and efficiencies
Eur J Pharm Sci. 2022 Jun 1;173:106181.
Dubbelboer IR, Sjögren E